Financial Report 2006 This Information is Intended for Investors CoverFinancial Review Introduction Overview of Our Performance and Operating Environment Accounting Policies Analysis of the Consolidated Statement of Income Revenues Revenues Major Pharmaceutical Products Animal Health Costs and Expenses Adjusted Income Financial Condition, Liquidity and Capital Resources New Accounting Standards Forward Looking Information and Factors That May... Management Report on Internal Control Audit... Report of Independent Registered Public Accounting... Internal Control Over Financial Reporting Consolidated Statements of Income Consolidated Balance Sheets Consolidated Statements of Shareholders?Equity Consolidated Statements of Cash Flows Notes to Consolidated Financial Statements Note 1 - Significant Accounting Policies Note 2 - Acquisitions Note 3 - Discontinued Operations Note 4 - Adapting to Scale Productivity Initiative Note 5 - Acquisition-Related Costs Note 6 - Other (Income)/ Deductions ?Net Note 7 - Taxes on Income Note 8 - Other Comprehensive Income/(Expense) Note 9 - Financial Instruments Note 10 - Inventories Note 11 - Property, Plant and Equipment Note 12 - Goodwill and Other Intangible Assets Note 13 - Pension and Postretirement Benefit Plans and... Note 14 - Equity Note 15 ?Share-Based Payments Note 16 - Earnings Per Common Share Note 17 - Lease Commitments Note 18 - Insurance Note 20 ?Segment, Geographic and Revenue... Quarterly Consolidated Financial Data (Unaudited) 2006 Quarterly Consolidated Financial Data (Unaudited) 2005 Financial Summary Page 1 of Advisory Information for Investors Page 1 of Download Full PDF
